Molecular basis of Cromer blood group antigens

被引:21
作者
Lublin, DM
Kompelli, S
Storry, JR
Reid, ME
机构
[1] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[2] New York Blood Ctr, New York, NY 10021 USA
关键词
D O I
10.1046/j.1537-2995.2000.40020208.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The Cromer blood group system consists of 10 antigens located on decay-accelerating factor (DAF). Previous molecular genetic analysis has determined the basis for four of these antigens. The present study was undertaken to identify the mutations that determine the remaining antigens. STUDY DESIGN AND METHOD: Existing or new data were used to localize each Cromer system antigen to a specific short consensus repeat (SCR) domain of DAF. The exon encoding that SCR domain was amplified by using the polymerase chain reaction (PCR) on genomic DNA obtained from individuals of that Cromer phenotype, and the DNA product was subjected to DNA sequence analysis. RESULTS: The TCa/TCc polymorphism is due to an R18P amino acid substitution in SCR1 of DAF. The Es(a+)/Es(a-) polymorphism is due to an I46N mutation in SCR1 of DAF. The WESb/WESa polymorphism is due to an L48R mutation in SCR1 of DAF. The UMC+/UMC-polymorphism is due to a T216M substitution in SCR4 of DAF. CONCLUSIONS: With information from previous reports and the findings of this study, the molecular genetic basis of all known alleles of the Cromer blood group system has been elucidated. Single amino acid substitutions are responsible for 9 of the 10 antigens (all except the multiple-epitope antigen IFC).
引用
收藏
页码:208 / 213
页数:6
相关论文
共 26 条
[1]   DECAY-ACCELERATING FACTOR (CD55), A GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED COMPLEMENT REGULATORY PROTEIN, IS A RECEPTOR FOR SEVERAL ECHOVIRUSES [J].
BERGELSON, JM ;
CHAN, M ;
SOLOMON, KR ;
STJOHN, NF ;
LIN, HM ;
FINBERG, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) :6245-6248
[2]   Use of recombinant DAF proteins to localize the epitopes recognized by monoclonal anti-CD55 [J].
Brodbeck, WG ;
Medof, ME .
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1997, 4 (01) :125-126
[3]   CLONING OF DECAY-ACCELERATING FACTOR SUGGESTS NOVEL USE OF SPLICING TO GENERATE 2 PROTEINS [J].
CARAS, IW ;
DAVITZ, MA ;
RHEE, L ;
WEDDELL, G ;
MARTIN, DW ;
NUSSENZWEIG, V .
NATURE, 1987, 325 (6104) :545-549
[4]  
COYNE KE, 1992, J IMMUNOL, V149, P2906
[5]   CROMER-RELATED ANTIGENS - BLOOD-GROUP DETERMINANTS ON DECAY-ACCELERATING FACTOR [J].
DANIELS, G .
VOX SANGUINIS, 1989, 56 (04) :205-211
[6]   Hemagglutination inhibition of Cromer blood group antibodies with soluble recombinant decay-accelerating factor [J].
Daniels, GL ;
Green, CA ;
Powell, RM ;
Ward, T .
TRANSFUSION, 1998, 38 (04) :332-336
[7]  
Daniels GL, 1998, TRANSFUSION MED, V8, P141
[8]   ANOTHER EXAMPLE OF ANTI-TCA [J].
GORMAN, MI ;
GLIDDEN, HM ;
BEHZAD, O .
TRANSFUSION, 1981, 21 (05) :579-579
[9]   ADSORPTION OF ANTI-CRA BY HUMAN PLATELET CONCENTRATES [J].
JUDD, WJ ;
STEINER, EA ;
MISKE, V .
TRANSFUSION, 1991, 31 (03) :286-286
[10]   TCA - A HIGH-FREQUENCY BLOOD-GROUP ANTIGEN [J].
LAIRDFRYER, B ;
DUKES, CV ;
LAWSON, J ;
MOULDS, JJ ;
WALKER, EM ;
GLASSMAN, AB .
TRANSFUSION, 1983, 23 (02) :124-127